Unlock instant, AI-driven research and patent intelligence for your innovation.

A method of determining analyte concentration

A technology for analysis and concentration, which is applied in the analysis of materials, material analysis by optical means, and measurement devices, etc. It can solve the problems of inapplicable flow cell inspection methods, inability to precipitate analytes, and inability to measure the total concentration of analytes, etc. question

Inactive Publication Date: 2009-11-18
GE HEALTHCARE BIO SCI CORP
View PDF4 Cites 16 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, as is known in the art, PEG does not precipitate all complexed analytes and thus does not enable measurement of the total analyte concentration
[0005] The two prior art methods described above require long incubation times and are therefore not suitable for flow cell assays

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A method of determining analyte concentration
  • A method of determining analyte concentration
  • A method of determining analyte concentration

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0070] Measurement of small amounts of anti-HSA antibodies in buffer in the presence of high concentrations of HSA

[0071] Human serum albumin (Sigma-Aldrich, Missouri, USA) was diluted to 50 μg / ml in 10 mM acetate pH 5.0 and immobilized on Flow cell 3 (Fc3) to about 9kRU in T100.

[0072] 100 μl samples containing 110 μg / ml HSA (Sigma-Aldrich) and different concentrations of anti-HSA (internal reagent) were prepared. As a control, samples not containing HSA were used.

[0073] Samples were acidified with 50 μl of 0.2M glycine pH 2.8.

[0074] Each sample is then injected into T100, using prototype injection Mix the sample with HBS-EP+ (0.1M HEPES, 0.15M NaCl, 3mM EDTA and 0.05% v / v Surfactant P20, pH 7.4-Biacore AB) at a ratio of 15:85, and in sequence Neutralize samples before passing through all flow cells of the IFC. Detection is carried out in Fc3 (previous experiments have shown that the mixing of acidic sample and neutralizing solution is optimal in the flow cel...

Embodiment 2

[0079] Anti-2-microglobulin was measured in buffer in the presence or absence of β-2-microglobulin by standard amine coupling (amine coupling kit, Biacore AB) with 10 mM acetate pH 4.5 (Biacore AB). 20 μg / ml β-2-microglobulin (β2μ) (internal reagent) in Flow cell 3 (Fc3) in T100 to about 1.7 kRU.

[0080] Prepare 100 μl buffer samples containing 100 μg / ml anti-β-2-microglobulin (anti-β2μ) (internal reagent) and different concentrations of β-2-microglobulin in HBS-EP+ (Biacore AB) ( β2μ) (internal reagent). Buffer samples were then acidified with 50 μl of 0.2M glycine, pH 2.8. Control samples were not acidified.

[0081] Each sample is then injected into T100, sample was mixed with HBS-EP+ (Biacore AB) at a ratio of 15:85 using prototype injection and neutralized before passing sequentially through all flow cells of the IFC. Regeneration was performed with glycine pH 1.5 (Biacore AB). The results are shown in Table II below.

[0082] Table II

[0083] β2μ(μg / ...

Embodiment 3

[0086] Measurement of anti-2-microglobulin in human plasma in the presence or absence of beta-2-microglobulin

[0087] 20 μg / ml β-2-microglobulin (β2μ) (internal reagent) in 10 mM acetate pH 4.5 (Biacore AB) was immobilized using standard amine coupling (Amine Coupling Kit, Biacore AB) on Flow cell 3 (Fc3) in T100 to about 1.7 kRU.

[0088] 100 μl human plasma samples were prepared containing either (i) 50 μg / ml anti-β2μ, or (ii) 50 μg / ml anti-β2μ and 5 μg / ml β2μ, and 1% v / v surfactant P20 (Biacore AB). (Human plasma samples typically contain about 1 μg / ml of β2μ). Plasma samples were then acidified (to give pH 2-3) with 15 μl of 1M HCl.

[0089] Each sample is then injected into T100, sample with 0.1MK using prototype injection 2 HPO 4 , pH 9.0, and 1% v / v surfactant P20 (Biacore AB) were mixed in a ratio of 15:85 and the samples were neutralized before passing through all the flow cells of the IFC in sequence. Regeneration was performed with glycine pH 1.5 (Biacore A...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

A method of determining the total concentration of an analyte in a fluid sample, wherein at least part of the analyte is present as a complex with an analyte-binding species comprises the steps of: a) subjecting the sample to conditions that reduce the binding affinity between analyte and analyte-binding species sufficiently to dissociate substantially any analyte complex and provide substantially all analyte in free form, b) subjecting the sample to conditions that restore the binding affinity between analyte and analyte-binding species, and c) immediately after the binding affinity has been restored, and before any substantial re-complexing of the analyte has taken place, determining the concentration of free analyte in the sample. A method of determining the concentration of complex-bound analyte in a sample is also disclosed.

Description

technical field [0001] The present invention relates to a method for determining the total concentration of an analyte in a fluid sample, wherein the analyte is at least partially present in the form of a complex, usually an immunocomplex. The present invention also relates to methods for determining the distribution of the total concentration of analyte in these fluids between the free and complex bound forms of the analyte. Background technique [0002] Immunogenicity is the ability or degree to which a particular substance is capable of eliciting an immune response, such as antibody production. In immunogenicity studies, there is increasing interest in measuring and quantifying components that are "hidden" in immune complexes. For example, in the study of protein drugs such as therapeutic antibodies, it is of interest to detect antibodies elicited against the drug. However, since the drug is present in relatively high concentrations in the serum, the anti-drug antibodie...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): G01N33/543G01N21/05G01N33/564G01N21/55G01N21/552
Inventor H·伯林T·贾赫德A·拉森H·鲁斯
Owner GE HEALTHCARE BIO SCI CORP